Robert K. Knight

Combined cytotoxic and progestogen therapy for advanced breast cancer

R. Rubens, J. Hayward, R. Begent, 1978, Cancer.

Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group.

G. Hortobagyi, R. Theriault, H. Wheeler, 1996, The New England journal of medicine.

Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group.

G. Hortobagyi, R. Theriault, J. Simeone, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adriamycin alone or combined with vincristine in the treatment of advanced breast cancer.

R. K. Knight, B. Cantwell, R. Rubens, 1983, European journal of cancer & clinical oncology.

Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group.

G. Hortobagyi, R. Theriault, H. Wheeler, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Markers of bone resorption in patients treated with pamidronate.

G. Hortobagyi, R. Theriault, V. Chinchilli, 1998, European journal of cancer.

Treatment of cancer-associated hypercalcemia. Double-blind comparison of rapid and slow intravenous infusion regimens of pamidronate disodium and saline alone.

R. Theriault, R. Navari, S. Madajewicz, 1994, Archives of internal medicine.

Safety and efficacy of bisphosphonates beyond 24 months in cancer patients.

G. Hortobagyi, F. Esteva, A. Lipton, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Contribution of prednisolone to the primary endocrine treatment of advanced breast cancer.

R. K. Knight, R. Rubens, J. Hayward, 1982, European journal of cancer & clinical oncology.